AGTR1 and colorectal carcinoma: Experimental animal models show a stimulatory effect of the key RAS peptide angiotensin (ANG) II through the ANG II type 1 receptor (AT1R) on tumour growth, while blockade this pathway inhibits tumour growth[6,7], including in a mouse model of CRC liver metastases [8].